broadly

The Challenges and Opportunities behind the Convergence of AI and Blockchain.

  Over the last decade, the potential overlap between cryptocurrency and artificial intelligence (AI) — two significant technological trends of the last decade. The curiosity stems from a natural inclination to find a connection between these innovative domains. On the surface, the synergy seems apparent: the decentralizing force of cryptocurrency could offset the centralizing tendencies of AI, while AI's complexity could be made more transparent through blockchain technologies, which are adept at data management and verification. However, the conversation often hit a snag when delving into concrete applications, leading to

Bitcoin, which goes hand in hand with AI technology, can we expect a continued bright outlook? 

Due to the full-scale introduction of AI technology in 2023, America's big tech companies such as Meta, Amazon, and Twitter are threatening human jobs by laying off more than 100,000 employees a year alone. In the aftermath of this, some experts say that the pace of AI development should be slowed down to prevent further harm to human jobs, but on the other hand, most experts believe that human development should proceed together in a society that coexists with AI, rather than slowing it down. There was also an opinion

Stablecoins Under Scrutiny

Amidst the market’s recovery from the recent onslaught of SEC crackdowns, rumors swirl over the potential targeting of stablecoins in their crosshairs. Such a move could have profound implications for cryptocurrency prices, making it crucial to gauge the likelihood of this scenario and the approach regulators might adopt. The largest stablecoins by market cap are Tether’s USDT and Circle’s USDC. Both are pegged to the US dollar and backed by various assets, typically highly liquid instruments like US Treasury bills. In theory, when someone wants to buy stablecoins from an

Verseon Acquires Edammo to Deepen Drug Discovery Approach

Published: Nov 12th, 2022 | By Mark Terry Verseon Corporation has acquired Edammo, an artificial intelligence-focused company, to deepen its own AI-based drug discovery platform, the companies revealed Tuesday. Adityo Prakash, co-founder and CEO of Verseon and Ed Ratner, CEO at Edammo, discussed the acquisition with BioSpace. “We develop completely new drugs on the computer, atom by atom, then we make them in the laboratory,” Prakash said. "We’re changing how small molecule drugs are designed and developed with a level of efficiency that hasn’t been possible before.” He added that